Introduction
Pre-eclampsia (PE) and gestational diabetes mellitus (GDM) are leading causes of complications during pregnancy with serious negative effects on the health of both the mother and her unborn child [1] [2] [3] . The pathophysiologies of both illnesses have been shown to be associated with each other [3] [4] [5] [6] . It appears that gestational diabetes and pre-eclampsia have several mechanisms in common: altered carbohydrate metabolism causes vascular changes such as arteriosclerosis and a glomerular filtration dysfunction, which results in a predisposition to pre-eclampsia. Some authors have recently discussed gestational diabetes as a risk factor of pre-eclampsia and pre-eclampsia as a possible consequence of gestational diabetes [5] . This theory is supported by a prospective random study that the treatment of gestational diabetes mellitus reduced the rate of pre-eclampsia by 30% [7] . Other authors cite dysfunctions such as increased insulin resistance as the cause of both illnesses [3, 4, 8, 9] . Several authors therefore have reached the conclusion that the state of research is inadequate and ambiguous [4, [8] [9] [10] for the difficulty of providing support for these explanations in the form of epidemiological data.
Epigenetics constitutes an important mechanism capable of regulating gene transcription, linking early life events to adult morbidity. Epigenetics entails heritable changes in chromatin that alter gene expression without changing the DNA sequence [11, 12] . DNA methylation is the most commonly studied epigenetic processes which is subject to developmental and environmental regulation and potentially modifiable with appropriate interventions [13] . It is primarily observed in CpG dinucleotides, which are underrepresented in the genome, generally at low density, but may be enriched in the promoter regions of genes [14, 15] . Elevated DNA methylation in such regions is generally associated with gene inactivity whereas a lack of methylation indicates the potential for gene expression.
The placenta function is directly linked to fetal development, and as such, placental dysfunction is implicated in many pregnancy-associated diseases [16] . Aberrant placental gene expression has been linked to pre-eclampsia, intrauterine growth restriction, gestational diabetes mellitus and gestational trophoblastic disease [17] [18] [19] [20] [21] [22] [23] . Given the link between gene expression and promoter methylation, it is reasonable to assume that aberrant expression in placental disease is associated with a disrupted DNA methylation profile or other epigenetic change [24] . Furthermore, epigenetics may provide a link between environmental factors that have previously been linked to poor pregnancy outcomes and fetal programming [25, 26] . It is reported that the patterns of genome-wide hypermethylation in promoters are widespread in the chorioamniotic membranes of early onset pre-eclampsia [27] and DNA methylome profiling of maternal peripheral blood and placentas reveal potential fetal DNA markers [28] .
The critical role of placenta in responding to intrauterine environment and the environment can influence the pattern of DNA methylation. The present study investigated genome-wide DNA methylation changes of pre-eclampsia and gestational diabetes mellitus to examine their association in human placentas. We found that the overall methylation patterns of placentas from PE and GDM women were similar, 64.4% (3348/5195) of the anno tated genes presented concor dant methylation changes. Additionally, several genes previously associated with carbohydrate metabolism with concordant methylation alterations were identified. This study will be helpful in exploring gestational diabetes mellitus and preeclampsia's having several mechanisms in common from the perspective of epigenetics.
Material and Methods

Human Samples
Human placental tissues were collected at the Maternal and Child Health Hospital (Nanjing, Jiangsu, China) with the approval of Nanjing Medical University, Human Research Ethics Committee. Patients were fully informed of the study and signed informed consent forms of their own accord. Sometimes these Information on maternal reproductive data, delivery characteristics, and infant outcomes were collected from maternal medical records and presented in Table 1 . Placentas were prepared within 10-15 minutes of delivery. Tissues were dissected and repeatedly rinsed until free from blood in chilled PBS (4 ℃). Placental lobules were always taken from the central region of the placenta, and the basal plate and chorionic surface were removed with the villous tissue obtained from the middle cross section. Dissected tissue was immediately snap frozen in liquid nitrogen and stored at -80 ℃ until ready for DNA extraction.
DNA extraction and modification DNA was extracted from the placenta samples using the QIAmp tissue kit (Qiagen, Hilden, Germany) following manufacturer's protocols. Purified DNA was quantified with the NanoDrop ND1000 spectrophotometer, and 1 μg of placental DNA was bisulfite modified using the EZ DNA ethylation Kit D5008 (Zymogen, # D5001).
DNA methylation microarray
DNA from placenta samples was fragmented by sonication to 300-1000 bp average size as determined on agarose gels. Enrichment of the methylated double-stranded DNA fraction by MIRA was performed as described previously [29, 30] . The labeling of amplicons, microarray hybridization, and scanning were performed according to the NimbleGen protocol. NimbleGen tiling arrays were used for hybridization (385 K Human CpG Island plus Promoter arrays). The single array design covers all 28,226 University of California, Santa Cruz (UCSC) Genome Browser-annotated CpG islands and the promoter regions for all RefSeq genes. The promoter region covered is 1 kb (-800 to + 200 relative to the transcription start sites). For all the samples, the MIRA-enriched DNA was compared with the input DNA. We conducted three technical replicates for each enrichment and hybridization, after which we averaged the log ratios for each replicate to produce one value per individual per locus.
Microarray Data Preprocessing
The Illumina GenomeStudio Software (version 2011.1) was used to assess quality and extract the DNA methyla tion signals from scanned arrays. Methylation data were extracted as raw signals with no background subtraction, and the data were normalized to control probes present on the array. Log 2 ratio data were converted into P-value scores using Student's t-test. Probes were selected as positive if their Pvalue scores were above 2 (P < 0.05). In addition, the multivariate characteristics (or Mahalanobis distance based on fitted mean vector and variance-covariance matrix) of array control probes supplied by NimbleGen were used to diagnose problems such as poor bisulfite conversion or color-specific problems; none were identified.
Gene Ontology (GO) and pathway analysis
We next used Gene Ontology analysis to investigate if any common functional trends are associated with the genes exhibiting differences from the PE and GDM groups compared with the control group. Those loci exhibiting a significance value of less than p < 0.05 from the Student's t-test were selected to include only those loci likely to demonstrate a true DNA-methylation difference between groups. We then mapped all gene candidates to GO terms in the database (http://www.geneontology.org/), calculating gene numbers for each term. Gene networks and canonical pathways representing key genes were identified using the curated IPA (Ingenuity Pathway Analysis) database according to KEGG, Biocarta, and Reatome, as previously [31] . Those loci exhibiting a significance value of less than p < 0.05 from the Student's t-test were selected to include only those loci likely to demonstrate a true DNA-methylation difference between groups. The threshold of significance was defined by the P-value and FDR.
Validation of the microarray finding
We further investigated samples from 85 placentas by bisulfite sequencing PCR (BSP), including 30 normal placentas, 28 placentas from women with GDM and 27 placentas from women with PE. Primers were designed with MethPrimer using the loci nominated from microarray analyses. The four pair primers were as PCR amplifications were performed with a standard hot-start PCR protocol in 25 µl volume reactions containing 3 µl of sodium-bisulfitetreated DNA, 1 mM primers, and a master mix containing hot-start Taq polymerase (Sigma). PCR conditions were as follows: 95 °C for 10 min, 40 cycles (95 °C/40 s; 50°C/40 s; 72 °C/40 s), and then 72 °C for 7 min. All PCR reactions were checked on a 1.5% agarose gel to ensure successful amplification. For BSP clone sequence analysis, the PCR products were subcloned into a pMD-19-T vector (Takara Bio, Inc., Japan). Ten to twenty clones were selected for sequencing to identify methylation differences between PE, GDM and control groups.
Statistical analysis.
The statistical significance of the methylation datasets was performed using a one-way ANOVA corrected for multiple comparisons followed by the Student's t-test with a significance of p < 0.05. Data from the bisulfite sequencing PCR experiments were analyzed with the Student's unpaired or paired t-tests where appropriate. Values are presented as mean + standard deviation. Table 1 describes the maternal and infant characteristics of the randomly generated training and testing datasets. All recruited women belonged to the same age group, however, the body mass index of patients from PE and GDM groups were significant different from control group. The duration of gestation was significantly lower in the control group when compared with the pre-eclampsia group and the gestational diabetes mellitus group. The systolic and diastolic blood pressure of pre-eclampsia women was significantly higher than normotensive women. Further, baby weight was significantly higher in the gestational diabetes mellitus group when compared with the control group. GDM and PE women had a 
Results
Maternal and neonatal characteristics
significantly greater BMI at their first antenatal visit (12 weeks gestation) when compared with the control group. Although fasting OGTT levels were not significantly different between groups, both 1-hour and 2-hour OGTT readings were significantly higher for GDM women.
It should be noted that we did not exclude the influence of BMI, whether it has some effects is still unknown. The breakdown of the Methyl-seq regions into specific annotated genomic elements and binding locations. Coordinates for promoters and other genic elements were calculated using the transcription start sites and gene annotations from the Known Genes file, compiled by the UCSC Genome Browser. (C) Chromosome location distribution of differentially methylated regions in PE and GDM samples. GDM, hypemethylated and hypomethylated regions of GDM placentas. PE-up, hypemethylated and hypomethylated regions of PE placentas.
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DNA methylation patterning in human placentas from PE and GDM patients
DNA methylation profiles were obtained on 85 human placenta samples using the NimbleGen DNA Methylation Analysis. We first compared the methylation profiles between PE and GDM to investigate whether placentas could represent a good source from which to profile methylation changes. We detected 8191 locis with differential methylation in placentas from PE patients and 10,424 locis in placentas from GDM cases ( Table 2 ). Further analysis showed that the overall methylation patterns of PE and GDM were similar, with more than 64.4% (3348/5195) of the total autosomal anno tated genes reported exhibiting consistent methylation (Fig. 1A) . 
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We assigned those regions exhibiting consistent methylation into distinct categories of genomic elements and then analyzed the Methyl-seq data in each sample according to each type of functional element. The annotated genomic elements are (1) promoters, (2) exons, (3) introns, and (4) intergenic regions. In Fig. 1B , we present the degree of DNA methylation for each genomic element in each sample. We observed that regions that include exons and intergenic region domains are more highly unmethylated (less than 16.8% of regions methylated), whereas regions including those occupied promoters and introns are more highly methylated (from 24.5% to more than 45.4% of the sites are methylated, Fig. 1B) . Thus, different genomic functional elements vary in their degree of DNA methylation.
Further analysis revealed that these regions with differential methylation are spread throughout the genome and cover all chromosomes (see Fig. 1C ). It is remarkable to see that chromosome 1 comprised the largest component of 10.5% with 1118 (PE) and 827 (GDM). There were only 127 (PE) and 118 (GDM) regions on chromosome 13 (1.3%). Illustrative CpG methylation levels for single chromosomes (chr 10 and chr 16) are shown in Fig. 2 . As shown in Table 3 , 52 hypomethylated regions constituted a significantly greater proportion of these regions; both changed more than threefold in PE and GDM patients, and 37 hypemethylated regions were present at a significantly higher level in PE and GDM patients (abundance changed more than fourfold). All regions involved showed statistically significant changes (p < 0.05).
Concordant variation of differen tially methylated loci in human placentas from PE and GDM patients
Differential methylation analysis applying the Illumina Custom model was performed after normalization to control probes present in the array and using the control group as ref erence. We identified 3394 probes in placentas from PE patients and 4021 in placentas same functional groups were affected in PE and GDM patients, with cell adhesion and cell division being the more populated clusters and including genes related to carbohydrate metabolism and lipid metabolism, molecular pathways largely implicated in PE and GDM in common.
Ingenuity Pathway Analysis was used to identify pathways and gene networks represented among the sets of protein-coding mRNAs identified in the VSD gene expression signature. In our survey of existing data, annotated genes that exhibited differences from GDM groups compared with the control group mainly involved the following pathways: (1) cell adhesion molecules (CAMs), (2) nicotinate and nicotinamide, (3) metabolism selenoamino acid metabolism, (4) cytokine-cytokine receptor interaction, (5) Wnt signaling pathway, (6) arachidonic acid metabolism, (7) glycolysis/gluconeogenesis, (8) toll-like receptor signaling pathway, (9) calcium signaling pathway, and (10) leukocyte transendothelial migration. The annotated genes exhibiting differences from GDM groups compared with the control group mainly involved the following pathways: (1) cell adhesion molecules (CAMs), (2) GnRH signaling pathway, (3) selenoamino acid metabolism, (4) MAPK signaling pathway, (5) Wnt signaling pathway, (6) arachidonic acid metabolism, (7) apoptosis, (8) toll-like receptor signaling pathway, (9) calcium signaling pathway, and (10) leukocyte transendothelial migration (Fig. 4) .
Site-Specific CpG-Methylation Analysis in Selected Genes
The above analyses suggest that a number of methylation changes in placentas are shared between PE and GDM, positioning these genes ( Table 2 ) that co-vary among tissues as can didates for biomarker discovery. To determine the potential association of these covarying genes between PE and GDM, we tested four genes' loci that have been confirmed as participating in carbohydrate metabolism or lipid metabolism to further verify the microarray approach. We quantitatively measured site-specific CpG methylation upstream of resistin (n = 15), GLUT3 (glucose transporter 3, n = 15), RBP4 (retinol binding protein 4, n = 15), PPARα (peroxisome proliferator-activated receptor alpha, n = 15). We focused primarily on surrounding CpG positions located in or near genomic regions corresponding to specific microarray probes.
Our site-specific CpG analyses show good consistency with data obtained from microarray analysis although the absolute differences observed are generally small. Two examples are shown in Fig. 5 for regions upstream of the genes' resistin and RBP4. Microarray analysis predicted these regions to be hypomethylated in PE and GDM samples. Fig. 5B shows BSP data confirming GLU3 hypermethylation both in PE and GDM samples compared with controls. BSP data also verified PPARα hypomethylation in samples from women with GDM. However, there is no significant methylation difference between PE groups and control groups (Fig. 5D ).
Discussion
Placental function is directly linked to fetal development and health, and as such, placental dysfunction is implicated in many pregnancy-associated diseases [18] . Accordingly, aberrant placental gene expression has been linked to pre-eclampsia, intrauterine growth restriction, gestational diabetes mellitus and gestational trophoblastic disease [19] [20] [21] [22] [23] [24] [25] . In this study, we performed a microarray-based epigenomic scan using human CpG-island plus Promoter microarrays and observed placenta-associated DNA methylation differences in numerous loci. Many genes that have been functionally linked to PE and GDM etiology were included. Consistent with increasing evidence, gestational diabetes mellitus and preeclampsia have several mechanisms in common. We identified epigenetic changes in lociassociated pathophysiologies of both illnesses with similar methylation patterns.
We identified 3394 probes in placentas from PE patients and 4021 in placentas from GDM patients with increased methylation whereas 4797 probes in placentas from PE (Table 2) . We further refined our analy sis to the fraction of autosomal probes showing differential methylation and associated with annotated genes, which corresponded to a total of 3878 genes in placentas from PE patients and 4656 annotated genes in GDM patients. Strikingly, 64.4% (3348/5195) of the anno tated genes with different methylation presented concor dant changes in methylation between PE and GDM patients ( Table 2) . Consistent with previous reports, although PE and GDM have distinctive clinical and pathophysiologic characteristics, they share some important similarities: both conditions develop during pregnancy, and the clinical syndromes disappear after delivery. Many risk factors such as obesity, elevated blood pressure, dyslipidemia, insulin resistance, and hyperglycemia are associated with both PE and GDM; and patients with a history of PE or GDM have increased risk of developing cardiovascular disease compared to women without such a history . Several interesting GO categories are highlighted by our analysis, including several involved in various epigenetic processes, transcription, and development. The top 15 GO categories for each diagnostic group can be observed in Fig. 2 , which lists all significant GO categories with a p < 0.05. Our results show that the same functional groups were affected in PE and GDM patients, with cell adhesion and cell differentiation being the more populated clusters (Fig. 2) ; including genes related to carbohydrate metabolism and lipid metabolism, the molecular pathways of PE and GDM are largely implicated in common. Our findings may represent alterations to such pathways related to PE and GDM, potentially linking the two pathological processes with carbohydrate metabolism and lipid metabolism pathways. Additional studies are warranted to expand on these examinations in later life endpoints to clarify the biological mechanisms at play.
It is important to note that we cannot definitively determine if these altered profiles of DNA methylation are a response of the placenta to the intrauterine environment and an independent association between these specific profiles of DNA methylation. Ongoing research is now revealing that gene-regulating methylation events may occur in regions outside of CpG islands such as the region of the regulated gene [32] . More comprehensive approaches including more inclusive arrays and genome-wide sequencing will be required to fully identify all regions contributing to PE and GDM We focused our investigation on methylation patterning because of the highly stable nature of DNA methylation marks. Previous studies have shown that labor induces altered expression of genes in the human placenta [33] , and although the methylation status is stable, the corresponding gene expression may not be [34] . Therefore, we believe that examination of methylation may reflect changes occurring over the course of in utero development and not only occurring in the final moments of pregnancy and delivery. We used a relatively unbiased, genome-wide method to identify locis whose methylation status in the placenta was most associated with PE and GDM.
Microarray analyses suggest that a number of methylation changes in the placenta are shared between PE and GDM, positioning these genes ( Table 2 ) that co-varied among tissues as can didates for biomarker discovery. To determine the potential association of those genes co-varying between PE and GDM, we tested four gene loci that have been confirmed as participating in carbohydrate metabolism and lipid metabolism to further verify the microarray approach. We quantitatively measured site-specific CpG methylation upstream of resistin, GLUT3, RBP4 and PPARα. GLUT3 as a high-affinity transporter has been implicated in the extraction of glucose from the fetal circulatory system for storage as glycogen in the placental endothelial cells [35] . GLUT3 upregulation in maternal diabetes is consistent with elevated glycogen depots in the placental endothelium in this condition. Aberrant GLUT3 expression was therefore suggested as contributing to fetal hyperglycemia in maternal diabetes [36] . It may likewise play a role in integrating environmental signals, resulting in altered placental function and GDM. Increased circulating RBP4 levels have been reported in several metabolic complications including obesity, insulin resistance, polycystic ovary syndrome and cardiovascular disease [37] . RBP4 is a physiological constituent of amniotic fluid [38] . Thus, DNA methylation of RBP4 target genes may affect the maternal- In conclusion, we report genome-wide alterations in DNA methylation associated with PE and GDM pathology in placentas. Although there are many differences in pathogenesis, we detected similar methylation patterns in both tissues. Significantly, we identified a set of genes whose methylation coordinately varies in PE and GDM placentas, with the majority of these loci previously being implicated in both pathologies. This study will be helpful in exploring gestational diabetes mellitus and pre-eclampsia's having several mechanisms in common from the perspective of epigenetics.
